信息搜索
信息关键字：药
  
『查询2022年信息』  『查询2021年信息』  『查询2020年信息』  『查询2019年信息』  『查询2018年信息』  『查询2017年信息』  『查询2016年信息』
『查询2015年信息』  『查询2014年信息』  『查询2013年信息』  『查询2012年信息』  『查询2011年信息』  『查询2010年信息』  『查询2009年信息』

分页[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239]

·华海药业：盐酸贝那普利片获药品注册证书有助于提升公司产品市场竞争力2023-4-11 18:22:25
·九典制药（300705）4月11日主力资金净卖出1232.94万元2023-4-11 16:41:16
·中关村：拟投建山东中关村医药产业园一期扩建项目2023-4-11 16:28:55
·【机构调研记录】鹏扬基金调研康辰药业、盛美上海等4只个股（附名单）2023-4-11 16:03:20
·【私募调研记录】高毅资产调研康辰药业、长江电力2023-4-11 15:33:54
·【机构调研记录】华宝基金调研康辰药业、四川黄金等5只个股（附名单）2023-4-11 15:29:42
·尔康制药：公司冻干粉针剂（八车间粉针剂生产线）通过GMP符合性检查2023-4-11 15:17:22
·德源药业4月14日召开2022年业绩说明会：扣非后净利1.04亿同比增长51.26%2023-4-11 14:26:21
·ETF追踪：昨日ETF净申购5.13亿元资金加仓创新药ETF2023-4-11 13:01:56
·【机构调研记录】兴合基金调研康辰药业、莱伯泰科2023-4-11 10:31:27
·吉春制药2022年净利4397.47万同比下滑16.84%物流停运发货受阻2023-4-11 10:27:57
·【私募调研记录】汐泰投资调研巨一科技、康辰药业2023-4-11 10:27:23
·【机构调研记录】惠升基金调研康辰药业、莱伯泰科2023-4-11 10:10:32
·【机构调研记录】财通基金调研中铁工业、康辰药业等4只个股（附名单）2023-4-11 9:24:54
·泰格医药年报有喜有忧，哪些因素在侵蚀净利润？2023-4-11 8:04:48
·东亚药业2022年净利1.04亿同比增长52.46%董事长池正明薪酬179.78万2023-4-11 6:53:48
·哈药股份2022年净利4.64亿同比增长25.14%总裁林国人薪酬361.71万2023-4-11 1:34:36
·弘森药业2022年净利9463.15万较上年同期增长90.63%2023-4-11 1:21:48
·宁波中药2022年净利103.54万同比扭亏为盈政府补助增加2023-4-10 23:17:47
·众生药业2022年净利3.22亿同比增长16%董事长陈永红薪酬49.87万2023-4-10 22:27:31

分页[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239]